Funding fuels expansion of the country’s most established developmental therapy model. Series C round led by aMoon Fund, B Capital and Flare Capital Partners with participation from Healthworx, ...
GEN: Can you speak to your experiences with scale-down screening model systems? Do you have a preference? Sieck: The best screening model depends on specific needs. An ideal small-scale model should ...
See how BioDlink’s digital-intelligence platform is driving three major improvements in lyophilization workflows.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback